Kerbside

The recommendations provided in this column are taken from various market sources such as brokers, analysts, dealers and investment strategists, etc. These recommendations may not be backed by strong fundamentals. Therefore we advise readers to use their own discretion before investing in these recommendation 

A STRONG FOUNDATION 

Edelweiss Financial Services
BSE Code: 532922
CMP: ₹ 94.04 



The word on the street is that Edelweiss Financial Services might just be the dark horse ready to deliver serious returns. The alternative asset management segment alone has seen a 17 per cent YoY jump in AUM, hitting ₹ 56,350 crore, while its mutual fund arm boasting a 24 per cent rise in AUM to ₹ 136,000 crore—with equity AUM skyrocketing by 71 per cent. But that’s not all. Edelweiss is laser-focused on trimming down its debt, slashing it by ₹ 2,670 crore over the past year. The general insurance premiums are up 56 per cent YoY. Add to that the deepening partnerships with heavyweights like SBI in housing finance, and you have a recipe for robust future growth. All signs point towards making it a stock to watch for handsome returns. 

NEW REVENUE AVENUE 

Eraaya Lifespaces
BSE Code: 531035
CMP: ₹ 800.35 

Eraaya Lifespaces is turning heads with its latest bold move. It has just secured ₹ 248.50 crore through a QIP and is not wasting any time putting it to work. The funds are set to finalise its acquisition of Ebix Inc., a heavyweight in the global software and e-commerce industry. This isn’t just a strategic buy—it’s a leap into new markets and industries that could reshape Eraaya’s future. With the acquisition already approved by the U.S. Bankruptcy Court, this acquisition will open doors to new revenue streams and markets, allowing Eraaya to leverage Ebix’s established presence. Keep an eye on this one since Eraaya is making all the right moves to potentially deliver substantial returns. 

DON'T MISS THE ACTION 

Hi-Tech Pipes
BSE Code: 543411
CMP: ₹ 184.45 

Hi-Tech Pipes, one of India’s leading manufacturers of ERW Steel Tubes and Pipes, is creating quite a buzz in the market. In the last quarter, the company achieved a record sales volume of 1,22,000 tonnes, with EBITDA more than doubling to ₹42.69 crore. This impressive performance is driven by a shift towards high-margin, value-added products and the successful commissioning of Sanand Unit-2 Phase-1. The company’s new rooftop solar power plant is set to cut energy costs, boosting profitability. Additionally, Hi-Tech Pipes recently secured a major order to supply ERW steel pipes to key players in the renewable energy sector. This has caught the attention of high-net-worth individuals (HNIs), who are now eyeing the stock with keen interest. 
 

GAINING ALL THE ATTENTION 

Panacea Biotec
BSE Code: 531349
CMP: ₹ 193.75 

Panacea Biotec, the innovative biotech company known for its vaccines and pharmaceuticals, is back in the spotlight. It has just received DCGI approval, alongside the Indian Council of Medical Research, to start Phase III trials for a dengue vaccine, DengiALL. With the recent Mpox outbreak, there’s growing buzz that Panacea’s stock is gaining traction among investors. Word from the dealer room is that this stock might be the one to watch as it draws serious attention in the market.